Fischer Medical [FISCHER] vs Nureca [NURECA] Detailed Stock Comparison

Fischer Medical

BSE
Loading...

Nureca

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Fischer Medical wins in 7 metrics, Nureca wins in 11 metrics, with 0 ties. Nureca appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricFischer MedicalNurecaBetter
P/E Ratio (TTM)1,197.22306.06Nureca
Price-to-Book Ratio35.601.19Nureca
Debt-to-Equity Ratio25.272.56Nureca
PEG Ratio-8.26-5.98Fischer Medical
EV/EBITDA849.13-15.99Nureca
Profit Margin (TTM)5.26%0.00%Fischer Medical
Operating Margin (TTM)14.89%-3.20%Fischer Medical
EBITDA Margin (TTM)14.89%N/AN/A
Return on Equity0.36%0.44%Nureca
Return on Assets (TTM)0.26%0.40%Nureca
Free Cash Flow (TTM)$-927.26M$-234.06MNureca
1-Year Return59.80%-25.08%Fischer Medical
Price-to-Sales Ratio (TTM)55.671.88Nureca
Enterprise Value$67.25B$1.13BFischer Medical
EV/Revenue Ratio53.580.91Nureca
Gross Profit Margin (TTM)45.56%35.11%Fischer Medical
Revenue per Share (TTM)$1$123Nureca
Earnings per Share (Diluted)$0.09$0.85Nureca
Beta (Stock Volatility)0.000.44Fischer Medical
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Fischer Medical vs Nureca Stock Performance Analysis

Loading Price Chart...

Fischer Medical
Nureca
Fischer Medical Stock Overview | Nureca Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fischer Medical-0.51%-5.37%-0.47%26.96%29.19%52.48%
Nureca3.25%4.35%-5.25%-16.86%6.15%-16.19%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fischer Medical59.80%893.99%3,779.06%1,435.00%-66.84%527.63%
Nureca-25.08%-74.01%-64.86%-64.86%-64.86%-64.86%

News Based Sentiment: Fischer Medical vs Nureca

Fischer Medical

News based Sentiment: POSITIVE

September was a remarkably positive month for Fischer Medical Ventures, driven by exceptional financial results, a successful listing on the NSE, and a shareholder-friendly stock split. These developments signal strong growth and investor confidence, making it a significant period for the company's investment story.

View Fischer Medical News Sentiment Analysis

Nureca

News based Sentiment: NEGATIVE

September was a challenging month for Nureca, marked by strong revenue growth offset by a significant decline in profitability and waning investor confidence. While a 'BUY' rating offers some optimism, the overall narrative points to substantial risks and the need for a turnaround in financial performance.

View Nureca News Sentiment Analysis

Performance & Financial Health Analysis: Fischer Medical vs Nureca

MetricFISCHERNURECA
Market Information
Market Cap i₹69.68B₹2.40B
Market Cap CategoryMid capSmall cap
10 Day Avg. Volume i31,86914,195
90 Day Avg. Volume i46,25915,377
Last Close₹107.45₹238.28
52 Week Range₹60.01 - ₹124.20₹203.62 - ₹447.50
% from 52W High-13.49%-46.75%
All-Time High₹2,386.00 (Apr 21, 2008)₹2,315.00 (Oct 04, 2021)
% from All-Time High-95.50%-89.71%
Growth Metrics
Quarterly Revenue Growth1.32%0.69%
Quarterly Earnings GrowthN/A-0.51%
Financial Health
Profit Margin (TTM) i0.05%0.00%
Operating Margin (TTM) i0.15%-0.03%
Return on Equity (TTM) i0.00%0.00%
Debt to Equity (MRQ) i25.272.56
Cash & Liquidity
Book Value per Share (MRQ)₹3.03₹194.28
Cash per Share (MRQ)₹3.94₹123.05
Operating Cash Flow (TTM) i₹-1,020,336,000₹-172,050,000
Levered Free Cash Flow (TTM) i₹12.08M₹8.46M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Fischer Medical vs Nureca

MetricFISCHERNURECA
Price Ratios
P/E Ratio (TTM) i1,197.22306.06
Forward P/E iN/AN/A
PEG Ratio i-8.26-5.98
Price to Sales (TTM) i55.671.88
Price to Book (MRQ) i35.601.19
Market Capitalization
Market Capitalization i₹69.68B₹2.40B
Enterprise Value i₹67.25B₹1.13B
Enterprise Value Metrics
Enterprise to Revenue i53.580.91
Enterprise to EBITDA i849.13-15.99
Risk & Other Metrics
Beta i0.000.44
Book Value per Share (MRQ) i₹3.03₹194.28

Financial Statements Comparison: Fischer Medical vs Nureca

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)FISCHERNURECA
Revenue/Sales i₹234.45M₹341.76M
Cost of Goods Sold i₹127.64M₹221.78M
Gross Profit i₹106.81M₹119.98M
Research & Development iN/AN/A
Operating Income (EBIT) i₹34.90M₹-10.93M
EBITDA i₹117.28M₹20.11M
Pre-Tax Income i₹101.75M₹12.31M
Income Tax i₹51.67M₹4.18M
Net Income (Profit) i₹50.08M₹8.13M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)FISCHERNURECA
Cash & Equivalents i₹1.04B₹32.41M
Total Current Assets i₹3.65B₹1.90B
Total Current Liabilities i₹1.02B₹123.99M
Long-Term Debt i₹172.06M₹25.90M
Total Shareholders Equity i₹3.38B₹1.94B
Retained Earnings i₹29.05M₹868.20M
Property, Plant & Equipment i₹89.03M₹70.13M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)FISCHERNURECA
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFISCHERNURECA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i31,86914,195
Average Daily Volume (90 Day) i46,25915,377
Shares Outstanding i638.02M10.00M
Float Shares i147.07M3.38M
% Held by Insiders i0.76%0.67%
% Held by Institutions i0.03%0.00%

Dividend Analysis & Yield Comparison: Fischer Medical vs Nureca

MetricFISCHERNURECA
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A₹0.00
Ex-Dividend DateN/AN/A